Shandong Boan Biotechnology Co., Ltd. (stock code: 06955) published its monthly return for equity issuer for February 2026. The announcement indicates no change in the company’s registered share capital, which remains at 622,333,694 shares at a par value of RMB 1 per share, totaling RMB 622,333,694. No increase or decrease in the issued shares was recorded; the balance at the close of the month was 622,333,694 issued shares with no treasury shares.

The announcement confirms compliance with the applicable public float requirement, which is at least 18.14% of the total issued share capital. This level was maintained as the minimum percentage of shares held by the public was approximately 18.14% of the total issued share capital. No other changes in warrants, convertibles, or other share issuance agreements were reported.